Lv51
1450 积分 2024-12-24 加入
Chinese consensus on first-line precision therapy for advanced gastric cancer
1个月前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
2个月前
已完结
The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development. The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development
5个月前
已完结
Perivascular Niche-Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment. Perivascular Niche-Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment
5个月前
已完结
Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody-Drug Conjugates
5个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2(+) breast cancer that limits trastuzumab deruxtecan efficacy
5个月前
已完结
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
5个月前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
5个月前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
8个月前
已完结
Efficacy and safety of disitamab vedotin in patients with human epidermal growth factor receptor 2-positive locally advanced or metastatic gastric cancer (including adenocarcinoma of the gastroesophageal junction): a single-arm, phase 2 study
10个月前
已关闭
皖公网安备34019202002308
